Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03873753
Other study ID # SLM 6
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date May 2, 2017
Est. completion date December 30, 2020

Study information

Verified date March 2019
Source Faculty Sao Leopoldo Mandic Campinas
Contact Sandra Regina E. da Silva, PhD
Phone +55 11 945179999
Email secheverria@uol.com.br
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Little is known regarding the effectiveness of neonatal oral hygiene and its relationship to colonization by Candida spp. in edentulous oral cavities. Thus, the objective of this study is to evaluate whether the oral hygiene of edentulous infants favors colonization by Candida spp. Newborns with up to 48 hours of life will randomly allocated to two groups. The mothers will instructed to clean the oral cavity with gauze and mineral water three times a day, in the test group, and not to clean, in the control group.


Recruitment information / eligibility

Status Recruiting
Enrollment 276
Est. completion date December 30, 2020
Est. primary completion date July 31, 2020
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group N/A to 2 Days
Eligibility Inclusion Criteria:

- A signed statement of informed consent

- Newborns up to 48 hours of life

- Exclusive breastfeeding

- Edentulous oral cavity

Exclusion Criteria:

- Any feeding other than breastfeeding

- Use of pacifier

- Digit sucking

- Systemic alterations

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Cleaning
Gauze and mineral water
No oral cleaning
Absence of cleaning

Locations

Country Name City State
Brazil Faculty Sao Leopoldo Mandic Campinas Sao Paulo

Sponsors (1)

Lead Sponsor Collaborator
Faculty Sao Leopoldo Mandic Campinas

Country where clinical trial is conducted

Brazil, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change from number of Candida spp CFU/mm3 Non-stimulated saliva will be collected with the aid of a sterile swab (Absorve®) from all infants. The samples were incubated at 37°C and analyzed after 48 hours to quantify the colony forming units (CFU/mm3) At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
Secondary Mean of patient's birth weight in the test group as assessed by questionnaire At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
Secondary Number of males in the test group as assessed by questionnaire At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
Secondary Number of cesarean delivery in the test group as assessed by questionnaire At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
Secondary Mean of patient's gestational week in the test group as assessed by questionnaire At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
Secondary Mean of patient's birth length in the test group as assessed by questionnaire At baseline as well as once a month until the eruption of the first tooth (up to 14 months)
See also
  Status Clinical Trial Phase
Not yet recruiting NCT03250923 - CelAgace™ OraRinse Solution for Treatment of Candidiasis Phase 1/Phase 2
Completed NCT00004781 - Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups N/A
Completed NCT03894839 - Evaluation of the Effect of Different Cleaning and Disinfection Procedures on the Involvement of Candida Species N/A
Completed NCT00128323 - A Comparison of Gentian Violet (GV) Mouth Washes, Nystatin, and Ketoconazole Tabs in Treating Oropharyngeal Candidiasis Phase 3
Recruiting NCT04410250 - Effect of Oral Hygienization in Newborn on Candida Spp Colonization N/A
Completed NCT02184351 - Clotrimazole vs. Mycelex® in Patients With Human Insufficiency Virus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis Phase 3
Completed NCT00665639 - Trial of Two Dosing Regimens of Micafungin Versus Caspofungin for the Treatment of Esophageal Candidiasis Phase 3
Completed NCT02818803 - Efficacy of Standardized-propolis Extract (EPP-AF®) Gel Formulation as Buccal Antiseptic Phase 3
Active, not recruiting NCT06120816 - Nitric Oxide Releasing Mouthwash (NORM) for the Management of Oropharyngeal Candidiasis Phase 1
Completed NCT00235053 - Study to Assess the Incidence of Local Oropharyngeal and Laryngeal Adverse Effects of Advair DISKUS 250/50 mcg BID Phase 4
Completed NCT00666185 - Comparative Trial of Micafungin Versus Fluconazole for Treating Esophageal Candidiasis Phase 3
Completed NCT00002446 - Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients Phase 3
Completed NCT00001448 - The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection N/A
Completed NCT00612963 - Novel Rinse to Treat in Oral Candidiasis in Cancer Patients N/A
Completed NCT00001812 - A Randomized, Double-Blind, Placebo Controlled Trial Evaluating the Impact of Nystatin on the Development of Oral Irritation in Patients Receiving High Dose Intravenous Interleukin-2 Phase 3
Completed NCT00000951 - A Study to Compare the Use of Fluconazole as Continuous Therapy Versus Periodic Therapy in HIV-Positive Patients With Recurrent Thrush Phase 4
Completed NCT00002057 - Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC N/A
Completed NCT00002431 - The Safety and Effectiveness of Peridex in Preventing or Delaying Fungal Infections of the Mouth in HIV-Infected Patients N/A
Completed NCT00001065 - A Study of Amphotericin B in the Treatment of Fungal Infections of the Mouth in HIV-Infected Patients Who Have Not Had Success With Fluconazole Phase 2
Completed NCT00002399 - A Comparison of SCH 56592 and Fluconazole in the Treatment of Oropharyngeal Candidiasis (OPC) in HIV-Positive Patients Phase 2